Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jul 10;51(13):3681-3.
doi: 10.1021/jm800521j. Epub 2008 Jun 18.

Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast

Affiliations

Hydrochalarones: a novel endohedral metallofullerene platform for enhancing magnetic resonance imaging contrast

Darren K MacFarland et al. J Med Chem. .

Abstract

Targeted imaging requires contrast agents that remain in the vasculature for extended periods of time. A new contrast agent is described in which gadolinium is encapsulated within an extremely stable carbon sphere, thus allowing for safe extended residence. Water solubility and small particle size is achieved with novel fullerene chemistry, attaching multiple oligoethylene glycol groups through nitrogen chemistry. These new compounds can be used to visualize tissue architecture in vivo with standard MRI techniques.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(A) General structure of Hydrochalarones is Gd3N@C80-Rx, where R = −[N(OH)(CH2CH2O)nCH3]x where n = 1,3,6 and x is 10–22. (B) Infrared spectra of Hydrochalarone-6.
Figure 2
Figure 2
Coronal slice from a whole-body MRI of a mouse before (left) and 30 min after (right) administration of Hydrochalarone-6. The unidentified bright spot in both the pre- and postcontrast images is likely an artifact.

Similar articles

Cited by

References

    1. Berrington de Gonzalez A, Darby S. Risk of cancer from diagnostic X-rays: estimates for the U.K. and 14 other countries. Lancet. 2004;363:345–351. - PubMed
    1. Marckmann P, Skov L, Rossen K, Dupont A, Damholt MB, Heaf JG, Thomsen HS. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol. 1996;17:2359–2362. - PubMed
    1. Grobner T. Gadolinium. A specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol, Dial, Transplant. 2006;21:1104–1108. - PubMed
    1. Bolskar RD, Benedetto AF, Husebo LO, Price RE, Jackson EF, Wallace S, Wilson LJ, Alford JM. First soluble M@C60 derivatives provide enhanced access to metallofullerenes and permit in vivo evaluation of Gd@C60[C(COOH)2]10 as a MRI contrast agent. J Am Chem Soc. 2003;125:5471–5478. - PubMed
    1. Mikawa M, Kato H, Okumura M, Narazaki Y, Kanazawa Y, Miwa N, Shinohara H. Paramagnetic water-soluble metallofullerenes having the highest relaxivity for MRI contrast agents. Bioconjugate Chem. 2001;12:510–514. - PubMed

Publication types